Literature DB >> 9973402

Evidence for repression of IL-2 gene activation in anergic T cells.

D G Telander1, E N Malvey, D L Mueller.   

Abstract

The induction of clonal anergy in a T cell inhibits IL-2 secretion because of the development of a proximal signal transduction defect. Fusion of anergic murine T cells to human Jurkat T leukemia cells and formation of heterokaryons failed to result in a complementation of this signaling defect and restoration of murine IL-2 mRNA inducibility. Instead, signal transduction to the human IL-2 gene became disrupted. Heterokaryons formed by the fusion of anergic murine T cells to normal murine T cells also failed to accumulate intracellular IL-2 protein in response to stimulation either with the combination of CD3 and CD28 mAbs or with ionomycin plus a protein kinase C-activating phorbol ester. The results argue against a loss-of-function signaling defect as the sole basis for clonal anergy induction and document the presence of a dominant-acting repressor molecule that inhibits signal transduction to the IL-2 gene within viable anergic T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973402

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

Authors:  A D Wells; M C Walsh; J A Bluestone; L A Turka
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  T-cell anergy: from phenotype to genotype and back.

Authors:  Christine M Seroogy; C Garrison Fathman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

4.  Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.

Authors:  Lillian Seu; Steffanie Sabbaj; Alexandra Duverger; Frederic Wagner; Joshua C Anderson; Elizabeth Davies; Frank Wolschendorf; Christopher D Willey; Michael S Saag; Paul Goepfert; Olaf Kutsch
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

Review 5.  Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance.

Authors:  Andrew D Wells
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

Review 6.  Transcriptional regulation of T cell tolerance.

Authors:  Sanmay Bandyopadhyay; Noemí Soto-Nieves; Fernando Macián
Journal:  Semin Immunol       Date:  2007-03-26       Impact factor: 11.130

Review 7.  mTOR at the crossroads of T cell proliferation and tolerance.

Authors:  Anna Mondino; Daniel L Mueller
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

8.  Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells.

Authors:  Sanmay Bandyopadhyay; Myrianne Duré; Monika Paroder; Noemí Soto-Nieves; Irene Puga; Fernando Macián
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

9.  Egr2-dependent gene expression profiling and ChIP-Seq reveal novel biologic targets in T cell anergy.

Authors:  Yan Zheng; Yuanyuan Zha; Robbert M Spaapen; Rebecca Mathew; Kenneth Barr; Albert Bendelac; Thomas F Gajewski
Journal:  Mol Immunol       Date:  2013-03-30       Impact factor: 4.407

10.  Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation.

Authors:  Kozo Ohkusu-Tsukada; Norio Tominaga; Heiichiro Udono; Katsuyuki Yui
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.